Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation

Bone Marrow Transplantation

Volumn 28, Issue 7, 2001, Pages 689-692

  Kanda, Y ^a   Mineishi, S ^a   Saito, T ^a   Saito, A ^a   Yamada, S ^a   Ohnishi, M ^a   Chizuka, A ^a   Niiya, H ^a   Suenaga, K ^a   Nakai, K ^a   Takeuchi, T ^a   Makimoto, A ^a   Tanosaki, R ^a   Kami, M ^a   Tanaka, Y ^a   Fujita, S ^a   Watanabe, T ^a   Kobayashi, Y ^a   Tobinai, K ^a   Takaue, Y ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Acyclovir; Hematopoietic stem cell transplantation; Prophylaxis; Varicella zoster virus

Indexed keywords

ACICLOVIR; BUSULFAN; CIPROFLOXACIN; CLADRIBINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUCONAZOLE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ALLOTRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES ZOSTER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LEUKEMIA; LONG TERM CARE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; VARICELLA ZOSTER VIRUS; VIRUS REACTIVATION;

ACYCLOVIR; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOLOGIC SURVEILLANCE; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDNISOLONE; RETROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; VIRUS ACTIVATION;

EID: 0034748416     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703214     Document Type: Article

References (13)

1. Varicella-zoster virus: Pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients
2. Treatment of varicellazoster virus infection in severely immunocompromised patients: A randomized comparison of acyclovir and vidarabine
3. Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro
4. The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation
5. Prevention of herpes zoster in patients by long-term oral acyclovir after allogeneic bone marrow transplantation
6. Long-term acyclovir prophylaxis for prevention of varicella zoster virus infection after autologous blood stem cell transplantation in patients with acute leukemia
7. Varicella-zoster infection after allogeneic bone marrow transplantation: Incidence, risk factors and prevention with low-dose aciclovir and ganciclovir
8. Pre-emptive therapy against cytomegalovirus (CMV) diseases guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: A single-center experience in Japan
9. Subclinical varicella-zoster virus viremia, herpes zoster, and T-lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation
10. Induction of acyclovir-resistant mutants of herpes simplex virus type I in athymic nude mice
11. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults
12. Famciclovir for the treatment of acute herpes zoster: Effects on acute disease and postherpetic neuralgia: A randomized, double-blind, placebo-controlled trial: Collaborative Fameiclovir Herpes Zoster Study Group
13. Management of acyclovir-resistant herpes simplex and varicella-zoster infections